SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

SAN

100.78

+1.63%↑

SHL.DE

48.13

-2.9%↓

ARGX

546.2

+3.64%↑

FRE

39.63

+2.4%↑

PHIA

22.7

-1.09%↓

Search

EssilorLuxottica SA

Aperta

SettoreSettore sanitario

254 -4.51

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

252.8

Massimo

268.5

Metriche Chiave

By Trading Economics

Entrata

-371M

994M

Vendite

-72M

13B

P/E

Media del settore

51.836

63.778

EPS

2.976

Rendimento da dividendi

1.48

Margine di Profitto

7.52

Dipendenti

153,498

EBITDA

635M

3.6B

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+7.78% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

1.48%

2.39%

Utili prossimi

17 apr 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1.2B

122B

Apertura precedente

258.51

Chiusura precedente

254

Notizie sul Sentiment di mercato

By Acuity

13%

87%

20 / 386 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

EssilorLuxottica SA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 feb 2025, 18:35 UTC

Utili

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

12 feb 2025, 17:32 UTC

Utili

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2 gen 2025, 17:29 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Buys AI Startup in Hearing Market Push

28 mar 2025, 08:57 UTC

Discorsi di Mercato

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13 feb 2025, 11:05 UTC

Discorsi di Mercato
Utili

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13 feb 2025, 10:54 UTC

Discorsi di Mercato
Utili

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

13 feb 2025, 08:41 UTC

Discorsi di Mercato
Utili

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

12 feb 2025, 17:05 UTC

Utili

EssilorLuxottica Backs Mid-Term Targets

12 feb 2025, 17:05 UTC

Utili

EssilorLuxottica 2024 Oper Pft EUR3.45B

12 feb 2025, 17:04 UTC

Utili

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

12 feb 2025, 17:04 UTC

Utili

EssilorLuxottica 2024 Net Pft EUR2.36B

12 feb 2025, 17:03 UTC

Utili

EssilorLuxottica 2024 Rev EUR26.51B

12 feb 2025, 17:03 UTC

Utili

EssilorLuxottica 4Q Rev EUR6.78B

12 feb 2025, 17:01 UTC

Utili

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

12 feb 2025, 17:00 UTC

Utili

EssilorLuxottica Declares Dividend of EUR3.95 a share

11 feb 2025, 16:30 UTC

Discorsi di Mercato

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

11 feb 2025, 10:58 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

11 feb 2025, 07:03 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Doesn't Disclose Financial Details

11 feb 2025, 07:03 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

11 feb 2025, 07:02 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

11 feb 2025, 07:01 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

11 feb 2025, 07:00 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica to Buy Cellview

2 gen 2025, 17:04 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Didn't Disclose Financial Details

2 gen 2025, 17:03 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

2 gen 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica: Pulse Audition Delivers AI-based Noise Reduction, Voice Enhancement

2 gen 2025, 17:01 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Acquires Pulse Audition

2 gen 2025, 17:00 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Strengthens Its Presence in Hearing Space With Acquisition of AI-driven Tech Startup in France

3 dic 2024, 16:21 UTC

Discorsi di Mercato

EssilorLuxottica Could Be Hit by U.S. Tariffs -- Market Talk

6 nov 2024, 09:01 UTC

Discorsi di Mercato

European Luxury Stocks Get Boost From Trump Potential Win -- Market Talk

18 ott 2024, 07:08 UTC

Discorsi di Mercato
Utili

EssilorLuxottica Tries Soothe Nerves After Revenue Misses Forecasts -- Market Talk

Confronto tra pari

Modifica del prezzo

EssilorLuxottica SA Previsione

Obiettivo di Prezzo

By TipRanks

7.78% in crescita

Previsioni per 12 mesi

Media 288.2 EUR  7.78%

Alto 335 EUR

Basso 245 EUR

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per EssilorLuxottica SA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

11 ratings

7

Acquista

4

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

266.2 / 267.9Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

No Evidence

Sentiment

By Acuity

20 / 386 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.